Another opportunity I'm tracking is with Doximity (DOCS)—a trade I’m already involved in. I’ve been gradually scaling in more capital, as the price action continues to offer favorable entries that align with my strategy.
The stock recently broke out of a long-standing descending channel, and that breakout occurred on strong volume, which prompted my initial entry. Since then, it’s provided additional opportunities—both a few days ago and again today. As long as the price continues to behave well, I’ll continue to build the position.
Notably, today's price action showed a strong reaction with volume as it touched the 10 and 20 EMAs—both of which crossed today—adding to the probability of a continued move higher.
That said, earnings are scheduled in the coming days, and as always, it's crucial to be prepared for a negative reaction. Manage risk accordingly and be ready to reassess if the results don’t support the current trend.
The stock recently broke out of a long-standing descending channel, and that breakout occurred on strong volume, which prompted my initial entry. Since then, it’s provided additional opportunities—both a few days ago and again today. As long as the price continues to behave well, I’ll continue to build the position.
Notably, today's price action showed a strong reaction with volume as it touched the 10 and 20 EMAs—both of which crossed today—adding to the probability of a continued move higher.
That said, earnings are scheduled in the coming days, and as always, it's crucial to be prepared for a negative reaction. Manage risk accordingly and be ready to reassess if the results don’t support the current trend.
Dagangan aktif
DOCS isn’t performing its best today, but this is all part of normal market behavior. As long as our stop-loss hasn't been triggered, the plan is to stay in the trade and let it play out.So far, so good—the selling volume is relatively low, which suggests there isn’t strong pressure behind the move down. For now, we hold and stay patient unless the market tells us otherwise.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.